Faculty Profile

Dr. Angamuthu Selvapandiyan

Email : selvapandiyan@jamiahamdard.ac.in


Research Area :

Infectious Diseases, Cell and molecular biology, Vaccinology, Diagnostics, Parasitology


Name : Dr. Angamuthu Selvapandiyan

Gender : Male

Birth Date : -

Designation : HOD & Associate Professor

Department : Molecular Medicine

URL : orcid.org/0000-0002-2194-1534

Date of Joining : -

UG Courses : B.Sc. Biotechnology

PG Courses : M.Sc. Biotechnology, M.Sc. Biomedical Sciences,

Address : Department of Molecular Medicine, 3rd Floor, Main Building, Jamia Hamdard, New Delhi 110062

City : New Delhi

State : Delhi

Country : India

Email Address : selvapandiyan@jamiahamdard.ac.in

Phone [Residence] : -

Phone [Mobile] : -

No. Degree/Diploma Institute/ Organization Year Branch/Specialization
1 Ph. D.  (Philosophy of Doctorate ) 1988 Somatic Cell Genetics
2 M.Sc.  (Master of Science ) 1983 Plant Fungal Pathogenesis
3 B.Sc.  (Bachelor of Science ) 1981 Physics, Chemistry & Biology
No. Publication Journal Month Year
1 Selected publications out of 65 in total are shown. 2021
2 S. Zafar, S. Akhter, N. Garg, A. Selvapandiyan, GK. Jain, FJ. Ahmad. (2020) Co-encapsulation of Docetaxel and Thymoquinone in mPEG-DSPE-Vitamin E TPGS-Lipid nanocapsules for breast cancer therapy: Formulation Optimization and Implications on cellular and in vivo toxicity. Eur J Pharm Biopharm. 148: 10-26.. doi: 10.1016/j.ejpb.2019.12.016 (IF: 4.6) 2020
3 Naqvi N, Srivastava R, Selvapandiyan A, Puri N. 2020. Host Mast cells in Leishmaniasis: Friend or Foe? Trends Parasitol. Dec;36(12):952-956. doi: 10.1016/j.pt.2020.09.010. (IF: 8) 2020
4 Selvapandiyan, A*, S.L. Croft, S. Rijal, H.L. Nakhasi and N.K. Ganguly, (2019) Innovations for the elimination and control of visceral leishmaniasis. Plos. Negl. Trop. Dis. 13(9) e0007616 *Corresponding author (IF: 4.0) 2019
5 K. Ahuja, MA Beg, R. Sharma, A. Saxena, N. Naqvi, N. Puri, PK Rai, A. Chaudhury, R. Duncan, P. Salotra, H. Nakhasi, A. Selvapandiyan*, 2018. A novel signal sequence negative multimeric glycosomal protein required for cell cycle progression of Leishmania donovani parasites. BBA Mol. Cell Res. 1865:1148-1159. *Corresponding author (IF: 4.1) 2018
6 N. Naqvi, K. Ahuja, A. Selvapandiyan, R.Dey, H. Nakhasi and N. Puri 2017. Role of Mast cells in clearance of Leishmania through extracellular trap formation. Scientific Reports. 7:13240. | DOI:10.1038/s441598-017-12753-1 (IF: 4.0) 2017
7 Bhattacharya, P., Dey, R., Dagur, P.K., Joshi, A.B., Ismail, N., Gannavaram, S., Debrabant, A., Akue, A.D., Kukuruga, M.A., Selvapandiyan, A., McCoy, J.P., Nakhasi, H.L. 2016. Live attenuated Leishmania donovani centrin knock out parasites generate non-inferior protective immune response in aged mice against visceral leishmaniasis. PLOS Neglected Tropical Diseases, pp1-28. DOI.10.1371/journal.pntd.0004963 (IF: 4.0) 2016
8 K. Avishek, H. Kaushal, S. Gannavaram, R. Dey, A. Selvapandiyan, V. Ramesh, N. S. Negi, U. S. Dubey, Hira L. Nakhasi & P. Salotra 2016. Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs Scientific Reports 6:33059 | DOI: 10.1038/srep33059. (IF: 4.0) 2016
9 Dey. R., Natarajan G., Bhattacharya. P., Cummings, H., Dagur. P., Terrazas. C., Selvapandiyan. A., et al., 2014. Characterization of cross protection by genetically modified live attenuated Leishmania donovani parasites against L. Mexicana. J. Immunol. 193(7):3513-27. (IF: 4.9) 2014
10 Sreenivas, G., Dey, R., Kumar, A., Selvapandiyan, A., Poonam S. and Nakhasi, H.L. 2014. Biomarkers of safety and immune protection for genetically modified live attenuated Leishmania vaccines against visceral leishmaniasis – discovery and implications. Frontiers Immunol. 23;5:241 pages 1-9. (IF: 6.4) 2014
11 R. Dey, Pr. K. Dagur, A. Selvapandiyan, J. P. McCoy, P. Salotra, R. Duncan and H. L. Nakhasi. 2013. Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Non-pathogenic and Elicit Long Term Protective Immunity in BALB/c Mice. J. Immunol. 5:2138-49. (IF: 4.9) 2013
12 Selvapandiyan, A., R. Dey, S. Nylen, R. Duncan, D. Sacks and H. L. Nakhasi 2009. Evaluation of Safety and Protective Immunity of a Live Attenuated, Centrin-knockout, Leishmania donovani Parasite. J. Immunol. 183(3): 1813-20. (IF: 4.9) 2009
13 Kanswal S., Katsenelson N., Selvapandiyan A., Bram R.J., and Akkoyunlu M. 2008 Deficient TACI expression on B lymphocytes of newborn mice leads to defective immunoglobulin secretion in response to BAFF or APRIL J. Immunol; 181:976-990. IF: 4.9) 2008
14 Mahajan B., Selvapandiyan A., Gerald N.J.,Majam V., Zheng H, Tiwari J., Fujioka H., Moch K., Kumar N., Nakhasi H.L., Kumar S., 2008. Centrins, Cell Cycle Regulation Proteins in Human Malaria Parasite Plasmodium falciparum J Biol Chem; 283:31871-31883. (IF: 4.2) 2008
15 Selvapandiyan, A*., Stabler, K., Ansari A.A., Kerby S., Riemenschneider, J., Salotra P., Duncan R., Nakhasi H.L. 2005. Fluorescence-based multiplex PCR assay for rapid simultaneous detection of bacterial and parasitic pathogens. J. Mol. Diagn. 7(2):268-275. *Corresponding author. (IF: 5.6) 2005
16 K. Tomioka, M. Peredelchuk, X. Zhu, R. Arena, D. Volokhov, A. Selvapandiyan, K. Stabler, J. Riemenschneider, S. Colombini, K. Elkins, V. Chizhikov, G. Kaplan, H. Nakhasi, R. Duncan, 2005 Multiplex detection of blood borne and bioterror pathogens in blood with a DNA microarray. J. Mol. Diagn. 7:486-494. (IF: 5.6) 2005
17 Sreenivas G, Subba Raju BV, Singh R, Selvapandiyan A, Duncan R, Sarkar D, Nakhasi HL and Salotra P. 2004. DNA Polymorphism Assay Distinguishes Isolates of Leishmania donovani That Cause Kala-Azar from Those That Cause Post-Kala-Azar Dermal Leishmaniasis in Humans. J Clin Microbiol. 42(4):1739-1741. (IF: 5.9) 2004
18 Selvapandiyan, A*., Debrabant A, Duncan R, Muller J, Salotra P, Sreenivas G, Salisbury JL, Nakhasi H.L. 2004. Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania. J Biol Chem. 2004 279(24):25703-10. (IF: 4.2) 2004
19 Rajagopal, R., Agrawal, N., Selvapandiyan, A., Sivakumar, S., Ahmad, S. and Bhatnagar, R.K. 2002. Recombinantly expressed isozymic aminopeptidases from Helicoverpa armigera midgut display differential interaction with closely related cry proteins. Biochem. J. 370: 971-978. (IF: 4.1) 2002
20 Selvapandiyan, A., Arora. N., Rajagopal. R., Jalali. S.K., Venkatesan. T., Singh. S.P. and Bhatnagar. R.K. 2001. Toxicity analysis of N- and C-terminal deleted vagetative insecticidal protein from Bacillus thuringiensis. Appl. Environ. Microbiol. 2001 67(12): 5855-8. (IF: 4.0) 2001
21 Selvapandiyan, A., Duncan, R., Debrabant, A., Bertholet, S., Sreenivas, G., Negi, N., Salotra, P and Nakhasi, H.L. 2001. Expression of a mutant centrin of Leishmania donovani reduces the growth of the parasite. J Biol Chem, 276 (16): 43253-43261. (IF: 4.2) 2001
22 Majumder K., Fattah F.A., Selvapandiyan A., Bhatnagar R.K.,1995. Background-minimized Cassette Mutagenesis by PCR using cassette-specific Selection Markers: A Useful General Approach for Studying Structure-Function Relationships of Multisubstrate Enzymes. Genome Research. 4:212-218. (IF: 11.1) 1995
23 Selvapandiyan A., Bhatt P.N., and Mehta A.R. 1989. Growth inhibition of intact plants and in vitro cultures of Tobacco by culture filtrates of Fusarium oxysporum f. sp. nicotianae. Annals Bot. 64: 117-122. (IF: 4.0) 1989
No. Book Published Year
1 Kwang Poo Chang, Bala K. Kolli and Collaborators (A. Selvapandiyan), 2017. Overview of Leishmaniasis with Special Emphasis on Kala-azar in South Asia. S.K. Singh (ed.), Neglected Tropical Diseases – South Asia, Neglected Tropical Diseases, Springer. pp. 1-13. doi.org/10.1007/978-3-319-68493-2_1 (CHAPTER) 2017
2 Dey, R., Gannavaram, S., Selvapandiyan. A., Fiuza. J., Duncan. R., and Nakhasi, HL. 2014. Current Status and Future Challenges for the Development of Genetically Altered Live Attenuated Leishmania Vaccines. Ed by Satoskar, A., Durvasula, R., Pathogenesis of Leishmaniasis New Developments in Research. Springer, New York pp. 45-66 (CHAPTER) 2014
3 Salotra, P., Selvapandiyan, A., Sreenivas, G., Nakhasi, H.L. 2005 Gene Knock out mutants of Leishmania as potential vaccine candidates. In Trends and Research in Leishmaniasis Volume 5 series of Status Report on Tropical Diseases in India. Ed by D. Ragunath and R. Nayak. PP 265-286. (CHAPTER) 2005
4 Selvapandiyan, A. Rajagopal, R, and Bhatnagar, R.K. 1999. Prospects of delaying emergence of resistance in insects against insecticidal toxins of Bacillus thuringiensis. Proceedings of ‘Sorghum tissue culture, transformation and genetic engineering, workshop at ICRISAT, India. (CHAPTER) 1999
5 Agrawal, N., Khanna, Y.P., Selvapandiyan, A. and Bhatnagar, R.K. 1999. Biology of Delta-endotoxins produced by Bacillus thuringiensis. Editors: J.B. Tiwari, T.N. Lakhanpal, J. Singh, R. Gupta and B.P. Chawla Advances in Microbial Technology, APH, India pp. 7-12. (CHAPTER) 1999
6 Selvapandiyan A., Bhatnagar R.K., and Ahmad S., 1997. Engineering EPSP synthase of Bacillus subtilis for herbicide tolerance in crop plants. In Microbes for Health and Sustainable Environment; at JNUniv, New Delhi (Ed: Prof. Ajit Verma) Malhotra Pub. House, New Delhi pp. 159-169. (CHAPTER) 1997
7 Selvapandiyan A., and Bhatnagar R. K., 1993. Biology of carbon-phosphorus bond degradation. DAE Proc. on Photosynthesis and Plant Mol. Biol. By BRNC, Dept. of Atomic Energy, India. New Delhi. pp197-203. 1993
8 Selvapandiyan A., Mehta A.R. and Bhatt P.N., 1987. Selection of tobacco cell lines resistant to the culture filtrate of Fusarium oxysporum. In Plant Cell & Tissue culture of economically important plants (Ed. G.M. Reddy) pp. 153-155. 1987
No. Patent Description Year
1 1. LIVE ATTENUATED LEISHMANIA VACCINES. US patent number: WO 2005/021030, US 7,887,812 B2 (2011). 2011
2 2. Detection and discrimination of hepatitis c virus, human immunodeficiency virus type1 and hepatitis b virus. US patent number: WO 2007084567 A3 2010
3 3. LIVE ATTENUATED LEISHMANIA VACCINES. India patent number: 243725 2010
No. Achievement Description Year
1 Position: 2020 onwards as HEAD (Acting) at Dept of Food Technology (SIST), Jamia Hamdard, New Delhi 2020
2 Position: 2019 onwards as HEAD and Associate Professor at JH-Institute of Molecular Medicine (SIST), Jamia Hamdard, New Delhi 2019
3 1988-2017: Travel Grants from National and International organizations to participate and present in conferences at USA (San Francisco, Denver, Seattle, Woods Hole, Rhode Island, Baltimore), Japan, Italy, Brazil, Spain, Thailand and Sri Lanka 2017
4 Position: 2016 - 2019 as 'TEAM LEAD SCIENTIST' at JH-Institute of Molecular Medicine, SIST, Jamia Hamdard, New Delhi 2016
5 Position: 2009 - 2016 as 'TEAM LEAD SCIENTIST' at the Institute of Molecular Medicine, New Delhi 2009
6 'Centre Director’s Scientific Achievement' Award from CBER/FDA USA 2009
7 ‘Group Recognition Award’ to Chagas Disease Donor Screening Biological License Application Review Group by CBER/FDA USA 2007
8 2002 "Fellows Award for Research Excellence (FARE), NIH, USA 2002
9 Position: 1999-2009 as 'Tenure Track Visiting Scientist' at Food and Drug Administration, Bethesda MD USA 1999
10 Position: 1996 - 1999 as 'Senior Research Scientist' at International Center for Genetic Engineering and Biotechnology, New Delhi 1996
11 Position: 1988 - 1996 as 'Support Scientist' at United Nations Industrial Development Organization, New Delhi 1988